José Luis Ordoñez-Librado et al. 2022. L-DOPA/Capsazepine or L-DOPA/Rimonabant Co-Administration in an Experimental Parkinson Disease Model: Behavioral and Cellular Consequences. Issues and Developments in Medicine and Medical Research Vol. 5. (Feb. 2022), 35–60. DOI:https://doi.org/10.9734/bpi/idmmr/v5/2361C.